We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/Development and Validation of a Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) Method for the Quantification of Olanzapine and Its Impurity
PeriodicalsMedical Sciences

Development and Validation of a Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) Method for the Quantification of Olanzapine and Its Impurity

Checking your access to this record.

Abstract & Overview

Olanzapine is an atypical antipsychotic drug, and chromatography is the backbone of separation science. It is utilized in all research laboratories and pharmaceutical industries throughout the world. The current review article focuses on the development and validation of an RP-HPLC method for olanzapine. Method development and validation are important in new drug discovery, development, and manufacturing, as well as a variety of other human and animal investigations. An analytical technique is developed to compare a defined characteristic of a drug substance or drug product to established acceptance criteria. Accuracy, precision, specificity, linearity, range and limit of detection, limit of quantification, robustness, and system suitability testing are all covered by validation of HPLC methods according to ICH Guidelines.

Cite this record

Tejas Shivram Pachpute, Anil Pawar (2025). Development and Validation of a Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) Method for the Quantification of Olanzapine and Its Impurity. Journal of Internal Medicine and Pharmacology (JIMP), 2(01), 25–38. https://doi.org/10.61920/jimp.v2i01.42

Copy in another style

Pachpute, T. S., & Pawar, A. (2025). Development and Validation of a Reverse Phase High-Performance Liquid Chromatography (RP-HPLC) Method for the Quantification of Olanzapine and Its Impurity. Journal of Internal Medicine and Pharmacology (JIMP), 2(01), 25–38. https://doi.org/10.61920/jimp.v2i01.42
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.